Characteristics at the time of HCC diagnosis and treatment course.
Case | Age at HCC diagnosis, years |
Sex | Etiology | N of TACE cycle (s) |
Cumulative dose ofdoxorubicin (mg) | Use of sorafenib | Radiation therapy |
---|---|---|---|---|---|---|---|
1 | 46 | Male | HBV | 4 | 80 | No | No |
2 | 45 | Male | HBV | 2 | 60 | No | No |
3 | 64 | Male | Alcohol | 5 | 180 | No | Yes |
4 | 63 | Male | HBV | 2 | 100 | No | No |
5 | 64 | Male | HBV | 10 | 500 | Yes | No |
6 | 58 | Male | Alcohol | 14 | 700 | Yes | No |
7 | 54 | Male | Alcohol | 4 | 200 | No | No |
8 | 67 | Male | Cryptogenic | 4 | 200 | No | No |
Abbreviations: HBV, hepatitis B virus; HCC, hepatocellular carcinoma; TACE, transcatheter arterial chemoembolization.